07-75A50126R00001_RFP Att 7 Breakdown of Proposed Costs.xlsx

This is a Breakdown of Proposed Costs attachment for a Firm Fixed Price contract supporting the Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response Program. The pricing template covers a 60-month base period and one 60-month option period, with contract line items structured under CLIN 0001 (Base Period) and CLIN 1000 (Option Period 1).

The contractor must provide vaccine development and manufacturing services including: Candidate Vaccine Virus (CVV) development; cGMP Influenza Vaccine Master and Working Seed Lot production; research and investigational lot formulation; commercial-scale bulk antigen and adjuvant manufacturing; formulation, filling, labeling, and packaging services; storage and stability testing for both bulk and final container formats; analytical laboratory testing and assays; non-clinical and clinical studies; shipping and product disposal; emerging pathogen response capabilities; validation and technology transfer activities; and manufacturing enhancements. Pricing is structured as Firm Fixed Price (FFP) for major deliverables and Firm Fixed Unit Price (FFUP) for recurring services, with several line items marked as Not Separately Priced (NSP) including standard and additional data reporting. Most individual line item unit prices and quantities are left blank (TBD) for offeror proposal completion, requiring vendors to detail their pricing for each activity category across both the base and option periods.